In The News

February 25, 2022

Tumor tissue modified viral-HPV DNA test predicts HPV-driven oropharynx cancer recurrence

A blood test to detect circulating tumor DNA accurately predicted recurrence of HPV-driven oropharyngeal cancer after treatment, according to research presented at Multidisciplinary Head and Neck Cancers Symposium.

February 25, 2022

Circulating TTMV HPV Tumor DNA May Detect Recurrence of HPV-Driven Oropharyngeal Cancers

A blood test was able to accurately predict disease recurrence using circulating tumor tissue modified viral (TTMV)–human papillomavirus (HPV) DNA among patients treated for HPV-driven oropharyngeal squamous cell carcinoma, according to research presented at the 2022 Multidisciplinary Head and Neck Cancers Symposium.

ASTRO News Release

READ FULL ARTICLE
February 24, 2022

Tumor tissue modified viral (TTMV)-HPV DNA biomarker test predicts recurrence of HPV-driven oropharynx cancer after treatment

A large, multi-institutional study demonstrates that a blood test to detect circulating tumor DNA can accurately predict recurrence of human papillomavirus (HPV)-driven oropharyngeal cancer following treatment.

July 31, 2021

Natick company develops test to detect head and neck cancer that could lead to earlier diagnosis

A saliva-based diagnostic test that can detect HPV-related head and neck cancer has the potential to catch the disease earlier and even serve as a standard screening method, which the medical community currently lacks.

February 4, 2020

Study finds blood test accurately tracks HPV-linked head and neck cancer

An experimental blood test accurately detected HPV-linked head and neck cancer recurrence and confirmed when patients remained cancer-free, according to findings from a study led by University of North Carolina Lineberger Comprehensive Cancer Center researchers.

June 14, 2019

Researchers identify traits linked to better outcomes in HPV-linked head and neck cancer

Newswise — Using a new blood test that’s in development, University of North Carolina Lineberger Comprehensive Cancer Center researchers identified characteristics that could be used to personalize treatment for patients with a type of head and neck cancer linked to HPV infection.

October 30, 2018

Biomarker Blood Test Accurately Confirms Remission in HPV-associated Oral Cancer

San Antonio, Texas—A biomarker test that detects minute traces of cancer-specific DNA has been shown to determine whether patients with human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma are free from cancer following radiation therapy.

October 24, 2018

Liquid biopsy test confirms remission in HPV-associated oral cancer

A novel liquid biopsy test showed compelling specificity and sensitivity in detecting HPV DNA among patients who underwent chemoradiotherapy for HPV-associated oropharyngeal squamous cell carcinoma, according to findings presented at the American Society for Radiation Oncology Annual Meeting.

October 23, 2018

HPV blood test shows promise for tracking head and neck cancer after treatment

CHAPEL HILL – A new blood test developed by University of North Carolina Lineberger Comprehensive Cancer Center researchers shows promise for tracking HPV-linked head and neck cancer patients to ensure they remain cancer-free after treatment.